pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,561 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    WSD-0922
    Non-Small Cell Lung Cancer Wayshine Biopharma Inc
  • Phase 2
    WTX-330
    Colorectal Cancer$HOWL Werewolf Therapeutics, Inc.
  • Phase 2
    WVE-007
    Obesity$WVE Wave Life Sciences Ltd.
  • Phase 2
← prev
page 31 of 53
next →
131
Pain89
Neurology1
WVEN-531
Duchenne Muscular Dystrophy
$WVE Wave Life Sciences Ltd.
  • Phase 2
    Wiskott-Aldrich Syndrome
    Wiskott-Aldrich Syndrome Genethon SA
  • Phase 2
    XRX-101
    oxypurinol
    Coronavirus Disease 2019 (COVID-19) Associated Acute Lung…$XRTX XORTX Therapeutics Inc.
  • Phase 2
    XmAb bispecific antibody
    Unspecified Cancer$NVS NOVARTIS AG
  • Phase 2
    YA-101
    Multiple System Atrophy (Multi-System Degeneration) Yoda Pharmaceuticals Inc
  • Phase 2
    YG-1699
    Type 1 Diabetes (Juvenile Diabetes) Youngene Therapeutics Co Ltd
  • Phase 2
    YH-12852
    Diabetic Gastroparesis$PCSA Processa Pharmaceuticals, Inc.
  • Phase 2
    YH-42946
    Non-Small Cell Lung Cancer Yuhan Corp
  • Phase 2
    YL-13027
    Solid Tumor Shanghai Yingli Pharmaceutical Co Ltd
  • Phase 2
    YL-15293
    Colorectal Cancer Shanghai Yingli Pharmaceutical Co Ltd
  • Phase 2
    YPP-10
    Keratoconjunctivitis Sicca (Dry Eye) Yuyu Pharma Inc
  • Phase 2
    YR-001
    Atopic Dermatitis (Atopic Eczema) YIRUI Pharmaceutical Technology Co Ltd
  • Phase 2
    ZEN-3694
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Zenith Epigenetics Ltd
  • Phase 2
    ZEP-3
    Herpes Labialis (Oral Herpes) Shulov Innovative Science Ltd
  • Phase 2
    ZT-01
    Nocturnal Hypoglycemia Zucara Therapeutics Inc
  • Phase 2
    abefolastat tesaroxetan
    abefolastat tesaroxetan
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Clarity Pharmaceuticals Ltd
  • Phase 2
    abequolixron zinc
    abequolixron zinc
    Epithelial Ovarian Cancer Inspirna Inc
  • Phase 2
    acimtamig
    acimtamig [INN]
    Anaplastic Large Cell Lymphoma (ALCL) Affimed GmbH
  • Phase 2
    actinium (225Ac) lintuzumab satetraxetan
    Actimab A (actinium (225Ac) lintuzumab satetraxetan [INN])
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)$ATNM Actinium Pharmaceuticals, Inc.
  • Phase 2
    adrixetinib
    adrixetinib [INN]
    Solid Tumor Qurient Co Ltd
  • Phase 2
    adrulipase alfa
    adrulipase alfa [INN]
    Exocrine Pancreatic Insufficiency$GRDX GridAI Technologies Corp.
  • Phase 2
    afamitresgene autoleucel
    Tecelra (afamitresgene autoleucel)
    Myxoid Liposarcoma US WorldMeds LLC
  • Phase 2
    afimetoran
    afimetoran
    Systemic Lupus Erythematosus Beeline Medicines Corp
  • Phase 2
    agomelatine
    agomelatine [INN]
    Major Depressive Disorder$ANRO Alto Neuroscience, Inc.
  • Phase 2
    aguracingene cadoparvovec
    aguracingene cadoparvovec
    Achromatopsia$MGTX MeiraGTx Holdings plc
  • Phase 2
    albuvirtide LA
    Human Immunodeficiency Virus (HIV) Infections (AIDS) Frontier Biotechnologies Inc
  • Phase 2
    aleniglipron l-arginine
    aleniglipron l-arginine
    Overweight$GPCR Structure Therapeutics Inc.